Professor Sarah Tabrizi

Professor Sarah Tabrizi, a leading Huntington's disease researcher from University College London, discusses groundbreaking gene therapy that shows a 75% reduction in disease progression. This could dramatically improve quality of life for patients. She explains the clinical significance of these results, potential regulatory approval timelines, and how the treatment may change lives. The episode also highlights positive community initiatives, like a Happiness Project in schools and a revitalization effort in Mumbai, showcasing the power of kindness and connection.